630
Participants
Start Date
January 31, 2003
Primary Completion Date
September 30, 2008
Tipranavir
Ritonavir(r)
Comparator Protease Inhibitor (CPI)
1182.12.11016 Boehringer Ingelheim Investigational Site, Halifax
1182.12.11012 Boehringer Ingelheim Investigational Site, Hamilton
1182.12.11001 Boehringer Ingelheim Investigational Site, Ottawa
1182.12.11004 Boehringer Ingelheim Investigational Site, Toronto
1182.12.11006 Boehringer Ingelheim Investigational Site, Toronto
1182.12.11009 Boehringer Ingelheim Investigational Site, Toronto
1182.12.11014 Boehringer Ingelheim Investigational Site, Toronto
1182.12.11015 Boehringer Ingelheim Investigational Site, Monteal
1182.12.11003 Boehringer Ingelheim Investigational Site, Montreal
1182.12.11007 Boehringer Ingelheim Investigational Site, Montreal
1182.12.11013 Boehringer Ingelheim Investigational Site, Montreal
1182.12.60 Boehringer Ingelheim Investigational Site, Santurce
1182.12.62 Boehringer Ingelheim Investigational Site, Phoenix
1182.12.108 El Rio SIA, Tucson
1182.12.9 Boehringer Ingelheim Investigational Site, Berkeley
1182.12.23 Boehringer Ingelheim Investigational Site, Beverly Hills
1182.12.12 Boehringer Ingelheim Investigational Site, Fountain Valley
1182.12.76 Boehringer Ingelheim Investigational Site, Long Beach
1182.12.1 Boehringer Ingelheim Investigational Site, Los Angeles
1182.12.59 David Geffen School of Medicine at UCLA, Los Angeles
1182.12.82 Boehringer Ingelheim Investigational Site, Los Angeles
1182.12.97 Boehringer Ingelheim Investigational Site, Los Angeles
1182.12.69 UC Davis Medical Center, Sacramento
1182.12.89 Boehringer Ingelheim Investigational Site, San Diego
1182.12.99 Boehringer Ingelheim Investigational Site, San Diego
1182.12.25 Boehringer Ingelheim Investigational Site, San Francisco
1182.12.5 Boehringer Ingelheim Investigational Site, San Francisco
1182.12.53 Boehringer Ingelheim Investigational Site, San Francisco
1182.12.98 University of Colorado Health Sciences Center, Denver
1182.12.7 Boehringer Ingelheim Investigational Site, Norwalk
1182.12.103 Boehringer Ingelheim Investigational Site, Washington D.C.
1182.12.52 Boehringer Ingelheim Investigational Site, Washington D.C.
1182.12.70, Washington D.C.
1182.12.79 Boehringer Ingelheim Investigational Site, Fort Lauderdale
1182.12.77 Boehringer Ingelheim Investigational Site, Fort Myers
1182.12.45 Boehringer Ingelheim Investigational Site, Miami
1182.12.75 CARES Resource, Miami
1182.12.85 Boehringer Ingelheim Investigational Site, Miami
1182.12.93 Boehringer Ingelheim Investigational Site, Miami Beach
1182.12.17 Boehringer Ingelheim Investigational Site, Orlando
1182.12.90 Boehringer Ingelheim Investigational Site, Sarasota
1182.12.63 Boehringer Ingelheim Investigational Site, Tampa
1182.12.78 Boehringer Ingelheim Investigational Site, Tampa
1182.12.94 Infectious Disease Research Institute, Tampa
1182.12.67 Boehringer Ingelheim Investigational Site, Vero Beach
1182.12.123 Infectious Disease Clinics of Emory, Atlanta
1182.12.88 Boehringer Ingelheim Investigational Site, Atlanta
1182.12.72 Boehringer Ingelheim Investigational Site, Decatur
1182.12.47 Boehringer Ingelheim Investigational Site, Macon
1182.12.8 Family Practice Medical Center, Boise
1182.12.105 Boehringer Ingelheim Investigational Site, Chicago
1182.12.3 Boehringer Ingelheim Investigational Site, Chicago
1182.12.49 Boehringer Ingelheim Investigational Site, Chicago
1182.12.32 Boehringer Ingelheim Investigational Site, Indianapolis
1182.12.48 Boehringer Ingelheim Investigational Site, Indianapolis
1182.12.33 Boehringer Ingelheim Investigational Site, Lexington
1182.12.44 Boehringer Ingelheim Investigational Site, Louisville
1182.12.95 Boehringer Ingelheim Investigational Site, New Orleans
1182.12.81 Boehringer Ingelheim Investigational Site, Portland
1182.12.30 Boehringer Ingelheim Investigational Site, Baltimore
1182.12.6 Boehringer Ingelheim Investigational Site, Bethesda
1182.12.100 Boehringer Ingelheim Investigational Site, Boston
1182.12.101 Boehringer Ingelheim Investigational Site, Boston
1182.12.41 Boehringer Ingelheim Investigational Site, Boston
1182.12.61 Boehringer Ingelheim Investigational Site, Springfield
1182.12.13 University of Michigan Health System, Ann Arbor
1182.12.54 Boehringer Ingelheim Investigational Site, Detroit
1182.12.56 Boehringer Ingelheim Investigational Site, Detroit
1182.12.120 Department of Medicine, HIV/AIDS Program, Minneapolis
1182.12.14 Dybedal Center for Clinical Research, Kansas City
1182.12.87 Boehringer Ingelheim Investigational Site, St Louis
1182.12.11 Wellness Center, Las Vegas
1182.12.4 Boehringer Ingelheim Investigational Site, Camden
1182.12.21 Boehringer Ingelheim Investigational Site, East Orange
1182.12.40 Boehringer Ingelheim Investigational Site, Santa Fe
1182.12.68 Boehringer Ingelheim Investigational Site, Albany
1182.12.34 Boehringer Ingelheim Investigational Site, Mount Vernon
1182.12.119 Boehringer Ingelheim Investigational Site, New York
1182.12.22 Boehringer Ingelheim Investigational Site, New York
1182.12.36 Boehringer Ingelheim Investigational Site, New York
1182.12.58 Beth Israel Medical Center, New York
1182.12.96 Boehringer Ingelheim Investigational Site, New York
1182.12.107 Boehringer Ingelheim Investigational Site, Rochester
1182.12.83 Boehringer Ingelheim Investigational Site, Stony Brook
1182.12.43 Boehringer Ingelheim Investigational Site, Valhalla
1182.12.42 Boehringer Ingelheim Investigational Site, Durham
1182.12.46 Boehringer Ingelheim Investigational Site, Huntersville
1182.12.109 Boehringer Ingelheim Investigational Site, Akron
1182.12.24 Boehringer Ingelheim Investigational Site, Cincinnati
1182.12.35 Boehringer Ingelheim Investigational Site, Cleveland
1182.12.65 Ohio State University Medical Center, Columbus
1182.12.80 Infectious Disease Institute Clinical Trials Unit, Oklahoma City
1182.12.114 Pinnacle Health, Harrisburg
1182.12.28 University of Pennsylvania, Philadelphia
1182.12.50 Boehringer Ingelheim Investigational Site, Philadelphia
1182.12.86 The Miriam Hospital, Providence
1182.12.10 Boehringer Ingelheim Investigational Site, Columbia
1182.12.116 Greenville Hospital System, Greenville
1182.12.2 Boehringer Ingelheim Investigational Site, Memphis
1182.12.106 Boehringer Ingelheim Investigational Site, Dallas
1182.12.55 Boehringer Ingelheim Investigational Site, Dallas
1182.12.31 Boehringer Ingelheim Investigational Site, Houston
1182.12.73 Boehringer Ingelheim Investigational Site, Houston
1182.12.26 Boehringer Ingelheim Investigational Site, San Antonio
1182.12.91 Boehringer Ingelheim Investigational Site, Annandale
1182.12.122 VCU Health Systems, Richmond
1182.12.15 Boehringer Ingelheim Investigational Site, Seattle
1182.12.29 Boehringer Ingelheim Investigational Site, Milwaukee
1182.12.1401 St. Vincent's Hospital, Darlinghurst
1182.12.1405 AIDS Research Initiative / Ground Zero, Darlinghurst
1182.12.1407 Holdsworth House General Practice, Darlinghurst
1182.12.1408 407 Doctors Pty Ltd., Darlinghurst
1182.12.1403 Albion Street Centre, Surry Hills
1182.12.1406 Gold Coast Sexual Health Clinic, Miami
1182.12.1404 Alfred Hospital, Melbourne
1182.12.11002 Boehringer Ingelheim Investigational Site, Vancouver
1182.12.11010 Boehringer Ingelheim Investigational Site, Winnipeg
Lead Sponsor
Boehringer Ingelheim
INDUSTRY